BioMarin Pharmaceutical Inc. (BMRN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 03:47PM EDT. Market open.
| Previous Close | 82.17 |
| Open | 82.33 |
| Bid | 81.03 x 200 |
| Ask | 81.29 x 200 |
| Day's Range | 81.13 - 83.09 |
| 52 Week Range | 76.02 - 99.56 |
| Volume | |
| Avg. Volume | 1,521,908 |
| Market Cap | 15.406B |
| Beta (5Y Monthly) | 0.32 |
| PE Ratio (TTM) | 76.58 |
| EPS (TTM) | 1.06 |
| Earnings Date | Apr 24, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 110.10 |
Insider MonkeyBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript April 24, 2024 BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.71, expectations were $0.6. BioMarin Pharmaceutical Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name […]
Simply Wall St.BioMarin Pharmaceutical First Quarter 2024 Earnings: EPS Beats Expectations
BioMarin Pharmaceutical ( NASDAQ:BMRN ) First Quarter 2024 Results Key Financial Results Revenue: US$648.8m (up 8.8...
ZacksBioMarin (BMRN) Beats on Q1 Earnings, Voxzogo Drives Sales
BioMarin's (BMRN) earnings beat estimates in the first quarter of 2024, while revenues slightly miss the mark. The company maintains revenue guidance for 2024.
© 2024 Yahoo. All rights reserved.